|
Feb 28
|
US High Growth Tech Stocks With Strong Potential
|
|
Feb 27
|
February 2025 Penny Stocks To Keep An Eye On
|
|
Feb 14
|
Q4 2024 Vanda Pharmaceuticals Inc Earnings Call
|
|
Feb 14
|
Vanda Pharmaceuticals Inc (VNDA) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges
|
|
Feb 13
|
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 13
|
Vanda: Q4 Earnings Snapshot
|
|
Feb 13
|
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 5
|
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
|
|
Feb 4
|
Vanda and AnaptysBio link for generalised pustular psoriasis therapy
|
|
Feb 3
|
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
|